Notice to Sole Source - Histowiz.docx
DOCX document 30 KB Posted
- Solicitation number
- 75N91024Q00155
About this file
This document is a Notice to Sole Source for a federal contract opportunity. The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Urologic Oncology Branch (UOB) plans to procure, on a sole source basis, a study to perform digital annotations on 1,912 digital images of whole-mount radical prostatectomy slides. The services must be provided by sub-specialty trained genitourinary pathologists, as the results will be used to develop artificial intelligence (AI) algorithms for prostate magnetic resonance imaging (MRI). Histowiz, Inc., a commercial pathology company, is the identified sole source vendor as they have performed these services for UOB in the past and have access to the required specialized pathologists. The response due date is August 13, 2024. This acquisition will be processed under FAR Part 12 for Commercial Items and is exempt from the requirements of FAR Part 6 for full and open competition.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
GENERAL INFORMATION/CLASSIFICATION
| Title: |
| Digital Annotation of Whole-Mount Radical Prostatectomy Histopathology Slides |
| Notice Type: |
| Pre-Solicitation |
| Solicitation Number: |
| 75N91024Q00155 |
| Posted Date: |
| 8/7/2024 |
| Response Date: |
| 8/13/2024 |
| PSC Code: |
| Q301 Medical-Laboratory Testing |
| NAICS Code: |
| 541380 Testing Laboratories |
ISSUED BY: National Institutes of Health (NIH), National Cancer Institute (NCI), Office of Acquisitions (OA)
DESCRIPTION:
The Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), the Urologic Oncology Branch (UOB), plans to procure, on a sole source basis, a study to perform digital annotations on 1,912 digital images of whole-mount radical prostatectomy slides.
Histowiz, Inc 760 Parkside Ave, Ste 121 Brooklyn, NY 11226
The response close date of the notice for this requirement is in accordance with FAR 5.203(b). This acquisition will be processed under FAR Part 12 – Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.106-1 (b)(1) and is exempt from the requirements of FAR Part 6. The North American Industry Classification System code is 541380 Testing Laboratories and the business size standard is $16.5 million.
UOB requires the comprehensive digital annotation of images taken from whole-mount radical prostatectomy specimens. These services must be provided by sub-specialty trained genitourinary pathologists since the results will be utilized to further develop artificial intelligence (AI) algorithms specifically for prostate magnetic resonance imaging (MRI).
At UOB efforts are underway to use technology to digitally analyze histology images with the goals of gaining efficiency and accuracy in interpreting the image data. The increasing amounts of these images acquired created a burden for interpretation by UOB’s experts that reached unsustainable levels. Thus, UOB requires the assistance of sub-specialized genitourinary pathologists from outside the NIH for its timely completion.
The vendor HistoWiz Inc is a commercial pathology company that performed these digital annotation services for UOB in the past. The utilization of the same vendor for these annotation services will allow a rapid turnaround time and a seamless integration of the new data into the pre-existing annotated image data sets. Moreover, this vendor has identified three sub-specialty trained genitourinary pathologists within their network who can exclusively perform these services.
Furthermore, in the event additional subspecialty trained genitourinary pathologists are needed for this project, HistoWiz Inc can immediately recruit their services. To UOB’s knowledge, no other vendor can conduct the digital annotations exclusively by sub-specialized genitourinary pathologists within a reasonable time frame.
This notice is not a request for competitive quotations. However, if any interested party, especially a small business, believes it can meet the Government’s needs, it may submit a capability statement, proposal, or quote for the Government to consider. The response and any other information furnished must be in writing and must contain sufficient details to allow NCI to determine if the party can perform the requirement. Responses to this notice shall be submitted via email to Contract Specialist, David Romley, at David.Romley@nih.gov no later than 12:00 P.M. EST on Tuesday, August 13, 2024 (8/13/24). A determination by the Government not to compete this proposed requirement based upon responses to this notice is solely within the discretion of the Government. Information received will be considered for the purpose of determining whether to conduct a competitive procurement. The Government reserves the right to use the information provided by respondents for any purpose deemed necessary and legally appropriate. To receive an award, Contractors must be registered and have valid certification through SAM.GOV. Please reference the notice number 75N91024Q00155 on all correspondence.
***Please reference attached Statement of Work for more details pertaining to the nature of the work to be performed.*** Notice of Intent to Sole Source
File details come from the government source that posted it. Updated .